Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...

Up to 20,000 babies may have been affected by exposure to valproate since it was introduced. Some, like the government’s ...

1 In an alert to patients and doctors, the Medicines and Healthcare Products Regulatory Agency (MHRA) said that the drugs ... patients should “continue these drugs before surgery, have full risk ...

1 In an alert to patients and doctors, the Medicines and Healthcare Products Regulatory Agency (MHRA) said that the drugs, used for weight loss and diabetes, slow down the emptying of the person’s ...

The Macular Society has described the Medicines and Healthcare products Regulatory Agency’s (MHRA) decision to reject a treatment for late-stage dry AMD as “undoubtedly disappointing news.” ...

These are highlighted on the CAS website. The MHRA has produced a news story for further information. Its monthly drug safety update provides information for healthcare professionals covering the safe ...

MHRA has published guidance to medical device manufacturers on upcoming requirements around post-market surveillance New regulations come into force on 16 June that mandate more stringent data ...